Abstract
OBJECTIVES: To investigate the associations of phenotypic age acceleration (PhenoAgeAccel) with the risk of dynamic progression of asthma, and whether genetic risk and lifestyle influence these associations.</p>
STUDY DESIGN: This prospective cohort study included 320,337 adults without asthma and cardiovascular disease (CVD) from the UK Biobank. PhenoAgeAccel was calculated from chronological age and nine clinical biomarkers, and categorized into two groups: biologically younger (negative value) and biologically older (positive value).</p>
MAIN OUTCOME MEASURES: The primary outcomes were incident asthma, CVD, and all-cause mortality. A multi-state model was used to estimate the hazard ratios (HRs) of these associations.</p>
RESULTS: During a median 13.69-year follow-up, 9073 participants developed asthma, of whom 2061 subsequently developed CVD, and 23,401 died. Compared with biologically younger participants, biologically older participants had significantly higher risks for all transitions: from healthy to asthma (HR 1.29, 95% CI 1.23-1.34) and death (1.59, 1.54-1.63), from asthma to post-asthma CVD (1.28, 1.17-1.40) and death (1.37, 1.09-1.71), and from post-asthma CVD to death (1.44, 1.17-1.76). Biologically older participants with high genetic risk had higher risks of asthma (2.71, 2.46-2.98) and post-asthma CVD (1.91, 1.57-2.33) than biologically younger participants with low genetic risk. Compared with biologically younger participants with favorable lifestyles, biologically older participants with unfavorable lifestyles had higher risks of all transitions, with HRs ranging from 1.56 (1.21-2.02) to 3.43 (3.18-3.69).</p>
CONCLUSIONS: PhenoAgeAccel was significantly associated with increased risks of all disease-state transitions. It could be combined with genetic risk to identify participants at high risk for asthma and its adverse progression, potentially guiding targeted preventive interventions.</p>